adr_usa_0392|LEGN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0392|LEGN|1|Legend Biotech Corp Total Current Assets (Quarterly) (USD)|Legend Biotech Corp Cash and Short Term Investments (Quarterly) (USD)|Legend Biotech Corp Inventories (Quarterly) (USD)|Legend Biotech Corp Net PP&E (Quarterly) (USD)|Legend Biotech Corp Goodwill and Intangibles (Quarterly) (USD)|Legend Biotech Corp Total Liabilities (Quarterly) (USD)|Legend Biotech Corp Total Current Liabilities (Quarterly) (USD)|Legend Biotech Corp Total Long Term Liabilities (Quarterly) (USD)|Legend Biotech Corp Total Deposits (Quarterly) (USD)|Legend Biotech Corp Book Value (Quarterly) (USD)|Legend Biotech Corp Retained Earnings (Quarterly) (USD)|Legend Biotech Corp Treasury Stock (Quarterly) (USD)|Legend Biotech Corp EV to Revenues|Legend Biotech Corp EV to Earnings|Legend Biotech Corp EV to Free Cash Flow|Legend Biotech Corp EV to Assets (Quarterly)|Legend Biotech Corp PS Ratio|Legend Biotech Corp PE Ratio|Legend Biotech Corp Price to Book Value|Legend Biotech Corp PEG Ratio|Legend Biotech Corp Debt to Equity Ratio|Legend Biotech Corp Dividend Yield|Legend Biotech Corp Shareholder Yield (TTM)|Legend Biotech Corp Percent of Shares Outstanding Short|Legend Biotech Corp Total Receivables (Quarterly) (USD)|Legend Biotech Corp Total Payables (Quarterly) (USD)|Legend Biotech Corp Total Capital Stock (Quarterly) (USD)|Legend Biotech Corp Return on Invested Capital|Legend Biotech Corp Quality Ratio Score|Legend Biotech Corp Momentum Score|Legend Biotech Corp Beta (1Y)|Legend Biotech Corp Sustainable Growth Rate (TTM)|Legend Biotech Corp Institutional Investor Ownership Percentage|Legend Biotech Corp Average Diluted Shares Outstanding (Quarterly)|Legend Biotech Corp Total Employees (Annual)|Legend Biotech Corp EPS Diluted (Quarterly) (USD)|Legend Biotech Corp Shares Outstanding|Legend Biotech Corp Repurchase of Capital Stock (Quarterly) (USD)|Legend Biotech Corp Ordinary Shares Number (Quarterly)|Legend Biotech Corp Payout Ratio|Legend Biotech Corp Quick Ratio (Quarterly)|Legend Biotech Corp Normalized Diluted EPS (Quarterly) (USD)|Legend Biotech Corp Stock Buybacks (Quarterly) (USD)|Legend Biotech Corp Effective Tax Rate (TTM)|Legend Biotech Corp Return on Equity|Legend Biotech Corp Net Income (TTM) (USD)|Legend Biotech Corp Revenue (TTM) (USD)|Legend Biotech Corp Dividend Per Share (Quarterly) (USD)|Legend Biotech Corp Revenue (Quarterly) (USD)|Legend Biotech Corp Gross Profit (Quarterly) (USD)|Legend Biotech Corp SG&A Expense (Quarterly) (USD)|Legend Biotech Corp Pre-Tax Income (Quarterly) (USD)|Legend Biotech Corp Net Income (Quarterly) (USD)|Legend Biotech Corp Net Interest Income (Quarterly) (USD)|Legend Biotech Corp Price (USD)|Legend Biotech Corp Total Return Price (USD)|Legend Biotech Corp Enterprise Value (USD)|Legend Biotech Corp 30-Day Average Daily Volume|Legend Biotech Corp 1 Year Price Returns (Daily)||
adr_usa_0392|LEGN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0392|LEGN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
adr_usa_0392|LEGN|5|91|91|91|91|91|91|91|91||91|||1.41975308642||1.41975308642||1.41975308642||1.41975308642||91|1.42857142857||15.2857142857|91|91|91||||||30.6666666667|152.333333333|273.5|152.333333333|7|152.333333333|91||91|152.333333333|||||||152.333333333||152.333333333|152.333333333|152.333333333|152.333333333|1.42857142857|1.42857142857|1.42857142857|1.42028985507|||
adr_usa_0392|LEGN|6|1|1|1|1|1|1|1|1||1|||81||81||81||81||1|98||7|1|1|1||||||3|3|2|3|1|3|1||1|3|||||||3||3|3|3|3|98|98|98|69|||
adr_usa_0392|LEGN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
adr_usa_0392|LEGN|201812|||||||||||||||||||||||||||||||||||294||||||||||||||||||||||||||
adr_usa_0392|LEGN|201903||||||||||||||||||||||||||||||||||100.2122||-0.124||||||-0.1336|||||||10.053||3.861|-12.43|-12.43|1.715|||||||
adr_usa_0392|LEGN|201906||||||||||||||||||||||||||||||||||100.2122||-0.2874||||||-0.2874|||||||10.087||6.637|-28.466|-28.802|-0.019|||||||
adr_usa_0392|LEGN|201912|||||||||||||||||||||||||||||||||||645||||||||||||||||||||||||||
adr_usa_0392|LEGN|202003|271.221|246.476|1.334|91.344|0.491|380.816|112.431|268.385||-15.881||||||||||||||||64.917|0.022|||||||100.2122||-0.44|129.3524|-0.075|258.7048||2.1922|-0.4453|||||||11.546||9.975|-47.937|-44.228|-3.142|||||||
adr_usa_0392|LEGN|202006|673.391|637.95|1.668|96.375|0.978|371.864|115.031|256.833||401.001|||112.3369|-22.0691|-33.3728|6.2917|100.3906||13.7171|||||0.2547||67.405|0.026||||||23.5843|107.7759|700|-1.26|129.2426|0.075|258.4851||5.5459|-1.26||1.5078||-220.336|43.286||11.6||14.065|-134.876|-134.876|-0.088|42.56|42.56|4862.6151|208641.9667||35.24|34
adr_usa_0392|LEGN|202009|||||||||||||77.4331||-23.0036||72.8162||9.9494|||||0.7167|||||||||24.3497||||||||||||||||||||||30.87|30.87|3351.7691|245781.2333||27.62|